Cencora

Pune
51,000 Total Employees
Year Founded: 2023

Cencora Company Growth, Stability & Outlook

Updated on August 31, 2026

Cencora's Candidate Tradeoffs

If you’re weighing whether Cencora is the right fit, these are the core tradeoffs to consider.

  • Cencora places greater emphasis on steady, resilient growth and measured risk-taking than on frequent strategic pivots and bold experimental bets.

Cencora Employee Perspectives

In November, Cencora announced the appointment of Francois Mandeville as executive vice president, strategy and mergers and acquisitions, and Pawan Verma as executive vice president, chief data and information officer.

“Our evolved leadership structure, which is now a combination of internally developed talent and new outside expertise, will enable us to further build on our already strong position in the marketplace, while advancing our strategy with a focus on delivering exceptional customer service, accelerating our digital transformation and prioritizing investments that allow us to better support our customers’ evolving needs.”

Robert P. Mauch, President and CEO

What People Are Saying About Cencora

  • Strong Revenue Growth: Revenue has risen across multiple periods, including fiscal 2025 up about 9% to roughly $321 billion and mid‑single‑digit year‑over‑year increases in fiscal 2026 quarters. Disclosures also note Q4 FY2025 revenue of $83.7 billion, up 5.9% year over year.
  • Profitability: Adjusted operating income and EPS expanded, with FY2025 adjusted EPS up 16% to $16.00 and Q2 FY2026 GAAP EPS rising to $8.40 alongside a raised full‑year adjusted EPS outlook to about $17.70–$17.90. Management also indicated double‑digit adjusted operating income growth expected for FY2026.
  • Resilient & Sustainable Growth: Momentum spans FY2023–FY2026 to date, with revenue progressing from about $262 billion (FY2023) to $294 billion (FY2024) to $321 billion (FY2025) and continued gains in 2026. Portfolio refocusing and acquisitions in specialty care (e.g., Retina Consultants of America, OneOncology) are described as engines supporting ongoing expansion and margin mix.